Literature DB >> 26484435

Reduced prefrontal activation during working and long-term memory tasks and impaired patient-reported cognition among cancer survivors postchemotherapy compared with healthy controls.

Lei Wang1,2,3, Alexandra C Apple1,2, Matthew P Schroeder2, Anthony J Ryals4, Joel L Voss2,4,5, Darren Gitelman5,6,7, Jerry J Sweet8, Zeeshan A Butt4, David Cella4, Lynne I Wagner4.   

Abstract

BACKGROUND: Patients who receive adjuvant chemotherapy have reported cognitive impairments that may last for years after the completion of treatment. Working memory-related and long-term memory-related changes in this population are not well understood. The objective of this study was to demonstrate that cancer-related cognitive impairments are associated with the under recruitment of brain regions involved in working and recognition memory compared with controls.
METHODS: Oncology patients (n = 15) who were receiving adjuvant chemotherapy and had evidence of cognitive impairment according to neuropsychological testing and self-report and a group of age-matched, education group-matched, cognitively normal control participants (n = 14) underwent functional magnetic resonance imaging. During functional magnetic resonance imaging, participants performed a nonverbal n-back working memory task and a visual recognition task.
RESULTS: On the working memory task, when 1-back and 2-back data were averaged and contrasted with 0-back data, significantly reduced activation was observed in the right dorsolateral prefrontal cortex for oncology patients versus controls. On the recognition task, oncology patients displayed decreased activity of the left-middle hippocampus compared with controls. Neuroimaging results were not associated with patient-reported cognition.
CONCLUSIONS: Decreased recruitment of brain regions associated with the encoding of working memory and recognition memory was observed in the oncology patients compared with the control group. These results suggest that there is a reduction in neural functioning postchemotherapy and corroborate patient-reported cognitive difficulties after cancer treatment, although a direct association was not observed. Cancer 2016;122:258-268.
© 2015 American Cancer Society. © 2015 American Cancer Society.

Entities:  

Keywords:  cancer-related cognitive impairment (CRCI); functional magnetic resonance imaging (fMRI); patient-reported outcomes (PRO); recognition memory; working memory

Mesh:

Substances:

Year:  2015        PMID: 26484435      PMCID: PMC4707984          DOI: 10.1002/cncr.29737

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  42 in total

1.  Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

Authors:  Tim A Ahles; Andrew J Saykin; Charlotte T Furstenberg; Bernard Cole; Leila A Mott; Karen Skalla; Marie B Whedon; Sarah Bivens; Tara Mitchell; E Robert Greenberg; Peter M Silberfarb
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

Review 2.  MicroCog: assessment of cognitive functioning.

Authors:  R W Elwood
Journal:  Neuropsychol Rev       Date:  2001-06       Impact factor: 7.444

3.  Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study.

Authors:  Brenna C McDonald; Susan K Conroy; Tim A Ahles; John D West; Andrew J Saykin
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

Review 4.  The medial temporal lobe and recognition memory.

Authors:  H Eichenbaum; A P Yonelinas; C Ranganath
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

Review 5.  Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis.

Authors:  Michelle Monje; Jörg Dietrich
Journal:  Behav Brain Res       Date:  2011-05-23       Impact factor: 3.332

6.  Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.

Authors:  Michiel B de Ruiter; Liesbeth Reneman; Willem Boogerd; Dick J Veltman; Frits S A M van Dam; Aart J Nederveen; Epie Boven; Sanne B Schagen
Journal:  Hum Brain Mapp       Date:  2010-07-28       Impact factor: 5.038

7.  The frequency of cognitive impairment in patients with anxiety, depression, and bipolar disorder: an unaccounted source of variance in clinical trials.

Authors:  C Thomas Gualtieri; Dexter W Morgan
Journal:  J Clin Psychiatry       Date:  2008-07       Impact factor: 4.384

Review 8.  Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions.

Authors:  Christian J Nelson; Nina Nandy; Andrew J Roth
Journal:  Palliat Support Care       Date:  2007-09

9.  Evaluating the dimensionality of perceived cognitive function.

Authors:  Jin-Shei Lai; Zeeshan Butt; Lynne Wagner; Jerry J Sweet; Jennifer L Beaumont; Janette Vardy; Paul B Jacobsen; Pamela J Shapiro; Sheri R Jacobs; David Cella
Journal:  J Pain Symptom Manage       Date:  2009-06       Impact factor: 3.612

10.  Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response.

Authors:  Nelli Boykoff; Mona Moieni; Saskia Karen Subramanian
Journal:  J Cancer Surviv       Date:  2009-09-16       Impact factor: 4.442

View more
  14 in total

Review 1.  Clearing the fog: a review of the effects of dietary omega-3 fatty acids and added sugars on chemotherapy-induced cognitive deficits.

Authors:  Tonya S Orchard; Monica M Gaudier-Diaz; Kellie R Weinhold; A Courtney DeVries
Journal:  Breast Cancer Res Treat       Date:  2016-12-08       Impact factor: 4.872

Review 2.  Mapping cognitive deficits in cancer patients after chemotherapy: An Activation Likelihood Estimation meta-analysis of task-related fMRI studies.

Authors:  Jacqueline B Saward; Elizabeth G Ellis; Annalee L Cobden; Karen Caeyenberghs
Journal:  Brain Imaging Behav       Date:  2022-04-02       Impact factor: 3.224

3.  International Cognition and Cancer Task Force Recommendations for Neuroimaging Methods in the Study of Cognitive Impairment in Non-CNS Cancer Patients.

Authors:  Sabine Deprez; Shelli R Kesler; Andrew J Saykin; Daniel H S Silverman; Michiel B de Ruiter; Brenna C McDonald
Journal:  J Natl Cancer Inst       Date:  2018-03-01       Impact factor: 13.506

Review 4.  Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.

Authors:  Ana Dias-Carvalho; Mariana Ferreira; Rita Ferreira; Maria de Lourdes Bastos; Susana Isabel Sá; João Paulo Capela; Félix Carvalho; Vera Marisa Costa
Journal:  Arch Toxicol       Date:  2021-11-02       Impact factor: 5.153

5.  Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns.

Authors:  Alexandra C Apple; Anthony J Ryals; Kathryn I Alpert; Lynne I Wagner; Pei-An Shih; Mehmet Dokucu; David Cella; Frank J Penedo; Joel L Voss; Lei Wang
Journal:  Neuroimage Clin       Date:  2017-03-16       Impact factor: 4.881

Review 6.  Neuroimmunology of Behavioral Comorbidities Associated With Cancer and Cancer Treatments.

Authors:  Jessica C Santos; Leah M Pyter
Journal:  Front Immunol       Date:  2018-06-07       Impact factor: 7.561

7.  Investigation of chemotherapy-induced brain structural alterations in breast cancer patients with generalized q-sampling MRI and graph theoretical analysis.

Authors:  Tsung-Yuan Li; Vincent Chin-Hung Chen; Dah-Cherng Yeh; Shu-Ling Huang; Cheng-Nan Chen; Jyh-Wen Chai; Clayton Chi-Chang Chen; Jun-Cheng Weng
Journal:  BMC Cancer       Date:  2018-12-04       Impact factor: 4.430

8.  Brain cortical structural differences between non-central nervous system cancer patients treated with and without chemotherapy compared to non-cancer controls: a cross-sectional pilot MRI study using clinically-indicated scans.

Authors:  Mark S Shiroishi; Vikash Gupta; Bavrina Bigjahan; Steven Y Cen; Faisal Rashid; Darryl H Hwang; Alexander Lerner; Orest B Boyko; Chia-Shang Jason Liu; Meng Law; Paul M Thompson; Neda Jahanshad
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-11-17

Review 9.  Cognitive Effects of Cancer and Cancer Treatments.

Authors:  Tim A Ahles; James C Root
Journal:  Annu Rev Clin Psychol       Date:  2018-01-18       Impact factor: 22.098

10.  Central Nervous System Injury - A Newly Observed Bystander Effect of Radiation.

Authors:  Caitlin Feiock; Masashi Yagi; Adam Maidman; Aaron Rendahl; Susanta Hui; Davis Seelig
Journal:  PLoS One       Date:  2016-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.